| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |